Dietmar Berger Insider Profile
4 Followers
Dietmar Berger, CMO at Gilead Sciences, holds 19.25K shares in Gilead Sciences (Ticker: GILD), holds 85.68K shares in Atara Biotherapeutics (Ticker: ATRA).
Dietmar Berger has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dietmar Berger holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Dietmar Berger
Dietmar Berger's Trading History
Gilead Sciences
Jun 11, 2026
CMO
Uninformative Buy
32.80K
$2.82M
Atara Biotherapeutics
May 08, 2019
Global Head of R&D
Uninformative Sell
144.61K
$876.49K
List of latest transactions for each holding click on a transaction to see Dietmar Berger's performance on stock
You May Also Like
Dietmar Berger insider profile FAQ
What is the percentage of profitable transactions made by Dietmar Berger?
The percentage of profitable transactions made by Dietmar Berger is ―.
What is the average return per transaction made by Dietmar Berger?
The average return per transaction made by Dietmar Berger is ―.
What stocks does Dietmar Berger hold?
Dietmar Berger holds: GILD, ATRA stocks.
What was Dietmar Berger’s latest transaction?
Dietmar Berger latest transaction was an Uninformative Buy of $32.80K.
What was Dietmar Berger's most profitable transaction?
Dietmar Berger’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Dietmar Berger's role in Gilead Sciences?
Dietmar Berger's role in Gilead Sciences is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.